← Back to Search

INSTI Multiplex HIV-1/2 Syphilis AB test for Syphilis (PoSH Trial)

N/A

Waitlist Available

Research Sponsored by University of Alberta

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Individuals who would routinely be screened for syphilis and HIV

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6-12 months

Awards & highlights

PoSH Trial Summary

This trial will compare the accuracy of two point-of-care tests for syphilis and HIV.

PoSH Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

PoSH Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6-12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6-12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Diagnostic accuracy of the Multiplo TP/HIV test and the INSTI Multiplex HIV-1/HIV-2/Syphilis Antibody Test in field settings

Secondary outcome measures

Number returning for standard test results

Time to return for standard test results

PoSH Trial Design

1Treatment groups

Experimental Treatment

Group I: Individuals accessing screening for syphilis and HIVExperimental Treatment2 Interventions

Individuals at risk for syphilis and HIV (e.g. gay and bisexual men, indigenous communities experiencing a resurgence of syphilis, persons who inject drugs, etc) will undergo testing with both POCT and standard laboratory testing. Individuals testing positive for syphilis or HIV on the POCT will be informed that this is a preliminary positive and standard testing will be done. Individuals testing positive for syphilis on POCT may be offered treatment at the time of testing.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

INSTI Multiplex HIV-1/2 Syphilis AB test

2020

N/A

~1530

Multiplo Rapid TP/HIV test

2020

N/A

~1530

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor

886 Previous Clinical Trials

383,252 Total Patients Enrolled

Canadian Institutes of Health Research (CIHR)OTHER_GOV

1,340 Previous Clinical Trials

26,451,172 Total Patients Enrolled

1 Trials studying Syphilis

3,895 Patients Enrolled for Syphilis

Alberta Health servicesOTHER

157 Previous Clinical Trials

648,018 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still open opportunities for participants in this experiment?

"The public record on clinicaltrials.gov confirms that recruitment for this trial is still in progress, having first opened its doors to candidates on July 27th 2020 and last been updated on April 3rd 2022."

Answered by AI

What is the sum of individuals partaking in this experiment?

"Affirmative. According to clinicaltrials.gov, this investigation is actively soliciting participants. This study was initially advertised on July 27th 2020 and the most recent update was posted April 3rd 2022; 1500 patients are needed at a single research centre for the trial to go ahead."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Point of Care Tests for Syphilis and HIV

Ameeta Singh, BMBS, MSc 2020. "Point of Care Tests for Syphilis and HIV". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04514848.